Sun Pharmaceutical Industries Ltd announced shareholder approval for its Organon & Co acquisition. This significant milestone moves the pro...

AI is revolutionising Indian hiring by enhancing candidate preparation and employer verification processes. Companies now prioritise eviden...

Insolvency petition filed this week, A&M appointed as liquidator of B2B commerce company. Ten year old co has seen valuations crash 70% as ...

The company has successfully completed the cash tender offer, through wholly-owned subsidiary, Zara Merger Sub Inc, for all the outstanding...

State Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co....

Quant Mutual Fund is strategically focusing on under-owned, under-researched, and neglected market segments for higher alpha generation. Th...

HAB Pharma and Signature Phytochemicals have merged, creating a consolidated entity with a turnover of Rs600 crore. This strategic move aim...

Suven Pharmaceuticals and Cohance Lifesciences plan to merge and aim to double their revenue to Rs 6,000 crore by FY29 through organic and ...

The remedy requires Teva to divest the drug portfolio to 11 firms and marks the largest drug divestiture order in an FTC pharmaceutical mer...

Sun Pharma in a filing to BSE said that Ranbaxy shareholders will get 8 shares of Sun Pharma for every 10 stocks they hold. Both stocks end...

At end of trade, Sun Pharmaceutical Industries ended at Rs 1,039.85, up 1.55 per cent and Ranbaxy Laboratories closed at Rs 819.55 apiece, ...

Shareholders of Shasun Pharmaceuticals have approved its merger proposal with drug firm Strides Arcolab.

Shares of Strides Arcolab gained over 9 per cent today after the company and Shasun Pharmaceuticals announced their merger .

The approval is valid for six months, during which the company will apply to the High Court for further clearance of the proposal.

If talks succeed, the new entity will become India's third largest pharma co in terms of sales going forward after Sun Pharmaceuticals & Dr...

Drug firm Sun Pharmaceutical Industries today said its US-based subsidiary Caraco has successfully completed the tender offer to acquire Du...

Domestic drug firm Sun Pharmaceutical, which had acquired Israel-based Taro Pharma for 455 million dollar last year, today said the Israel-...